QualityStocksNewsBreaks Archives - Page 499 of 1476

TuesdayApr 19, 2022 3:42 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at Sequire Cannabis & Psychedelics Conference– SPYR Inc. (SPYR), Applied Magix Tease Upcoming Summer Sale with 50% Discounts

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company and its subsidiary, Applied Magix Inc., has announced that, during its upcoming Applied Magix Summer Sale, select products will be available for up to 50% off. Applied Magix develops and resells Apple(R) ecosystem compatible products in the growing multibillion-dollar smart home and connected car markets. The summer sale is designed to reduce inventory in preparation for upcoming product updates while also providing consumers with some of the best prices on its products. Products offered through the sale include MagixDrive, MagixCharge Dual USB-C charger, Onvis C3 HomeKit Secure Video Camera and Onvis C1 Security…

TuesdayApr 19, 2022 3:35 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at Sequire Cannabis & Psychedelics Conference

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty services to the worldwide biopharmaceuticals and other industries, today announced its participation as a presenter at the Sequire Cannabis & Psychedelics Investor Conference. The virtual event, taking place on April 20, 2022, will feature over 30 top public companies in the cannabis and psychedelics space. PBI’s president and CEO Richard T. Schumacher is scheduled to present, beginning at 10:30 a.m. ET, and will expand on the company's recent achievements in the nanoemulsification of CBD and other cannabinoids, as well…

TuesdayApr 19, 2022 2:58 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences Its Most Comprehensive Study to Date

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has begun its multi-week human clinical hypertension study. The randomized, double blinded, placebo-controlled, cross-over study in 60 people, HYPER-H21-4, is the most comprehensive study ever undertaken by Lexaria. HYPER-H21-4 is designed to enhance Lexaria’s probability of success with its expected subsequent Investigational New Drug (“IND”) application filing to seek U.S. Food and Drug Administration (“FDA”) approval to commence registered clinical testing at phase I level or higher, to be determined in consultation with the FDA. The human study is also expected to enhance Lexaria’s…

TuesdayApr 19, 2022 2:48 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Announces Continued Transaction Growth, Launch of Strategic India Node

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), an emerging technology company developing payment infrastructure for the Bitcoin Lightning Network (“LN”), today announced two important milestones. These include the company’s ten global routing nodes now collectively reaching over 10,000 transactions forwarded, as well as its deployment of a new routing node in India. Tech savvy and densely populated, India is ranked second in countries seeing the fastest growth in cryptocurrency adoption globally and has one of the strongest internet markets in the world, with approximately 750 million users. “We are experiencing excellent transaction growth since launching our first nodes in November 2021,”…

TuesdayApr 19, 2022 2:29 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Panels and Featured Speakers for 4/20 Event

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced speakers for the Sequire Cannabis & Psychedelic Conference taking place on April 20, 2022. The event will showcase over 30 cannabis and psychedelic companies hosting 25 minute presentations, one-on-one investor meetings, and keynotes highlighting notable names in these spaces. The panels and featured speakers include a discussion on “Exploring the Value and Application of Botanical and Synthetic Formulations in Psychedelic Medicine,” in which Dr. Matt Johnson, Joel Stanley and David Drapkin will discuss clinical research on…

TuesdayApr 19, 2022 2:09 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Releases 2021 Annual Financial Results, Names Newswire Partner

Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled provider of energy optimization and clean energy solutions for the U.S. commercial real estate industry, is reporting its audited annual financial numbers for the year ending Dec. 31, 2021. Highlights of the report include revenue for the year of $98,446 compared with $170,719 for fiscal year 2020 and gross profit of $9,695 compared to a loss of $65,259 in 2020. The company noted that the reduction in revenue was the result of its heavy focus in R&D and technology build-out now being commercialized in 2022. CIPI operating expenses decreased to $84,944 compared to…

TuesdayApr 19, 2022 1:38 pm

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) to Participate at Sequire Cannabis and Psychedelic Conference, Scottsdale Capital Event

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced that its co-founder and CEO Matt Stang will participate at the Sequire Cannabis and Psychedelic Conference and the Scottsdale Capital Event. Stang will present the company's performance and industry outlook and participate in one-on-one meetings with investors at the Sequire Cannabis and Psychedelic Conference. The virtual event, taking place on April 20, 2022, will bring together over 50 leading public companies in the cannabis, CBD and psychedelic space to discuss the future of their respective industries. In addition, Stang…

TuesdayApr 19, 2022 1:18 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Enters LOI with First Demonstration Project Partners

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) today announced its entry into a letter of intent (“LOI”) with Tracy and Curtis Hiebert, farmers based in Manitoba, Canada, making them the company’s first demonstration project partners. According to the update, FuelPositive’s first, full-sized, green ammonia production system will be placed on the Hiebert’s 11,000-acre family operated plant-crop farm near the town of Sperling, south of Winnipeg. The demonstration system will be fully validated and ready for the farm in late-summer 2022. “We are excited to be working with Tracy and Curtis and their family on our first demonstration project. They take a modern…

TuesdayApr 19, 2022 12:30 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Conferences

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, will be involved in several conferences in April and May. Company management will be participating at the Benzinga Spring Cannabis Capital Conference, scheduled for April 20–21, 2022, in Miami Beach, Florida. InMed executives will be meeting virtually with institutions and industry representatives. Company executives will also be at Canaccord Genuity’s sixth annual Global Cannabis Conference held on May 11, 2022. A recording of the company’s presentation will be available on InMed’s investor relations website following the event. Company leaders will also be available for…

MondayApr 18, 2022 2:34 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale

InMed Pharmaceuticals (NASDAQ: INM), a rare cannabinoid drug developer, is expanding its product manufacturing scale, thanks largely to the acquisition of consumer-focused rare cannabinoids manufacturer BayMedica last year. “InMed’s most-recent Q2 financial statement reported revenues of $0.3 million from commercial sales of cannabichromene (‘CBC’) to the health and wellness market following the BayMedica acquisition. Since January, the company has also been selling cannabicitran (‘CBT’) to the health and wellness market on a B2B basis,” a recent article reads. “The company’s forward-looking focus on bringing new cannabinoid products to commercial scale anticipates scales of cannabidivarin (‘CBDV’) and tetrahydrocannabivarin (‘THCV’) in the…

Site Search

Company Search

Category: QualityStocksNewsBreaks